Differential modulation of p38 mitogen activated protein kinase and STAT3 signalling pathways by infliximab and etanercept in intestinal T cells from patients with Crohn's disease (multiple letter) [9]

P. Rosenstiel; J. Agnholt; J. Kelsen; V. Medici; G. H. Waetzig; D. Seegert; S. Schreiber; A. Di Sabatino; R. Ciccocioppo; R. Morera; G. R. Corazza

Differential modulation of p38 mitogen activated protein kinase and STAT3 signalling pathways by infliximab and etanercept in intestinal T cells from patients with Crohn's disease (multiple letter) [9]

P. Rosenstiel, J. Agnholt, J. Kelsen, V. Medici, G. H. Waetzig, D. Seegert, S. Schreiber, A. Di Sabatino, R. Ciccocioppo, R. Morera, G. R. Corazza

IRCCS Fondazione Policlinico San Matteo

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	314-316
Number of pages	3
Journal	Gut
Volume	54
Issue number	2
Publication status	Published - Feb 2005

ASJC Scopus subject areas

Gastroenterology

Cite this

Rosenstiel, P., Agnholt, J., Kelsen, J., Medici, V., Waetzig, G. H., Seegert, D., Schreiber, S., Di Sabatino, A., Ciccocioppo, R., Morera, R., & Corazza, G. R. (2005). Differential modulation of p38 mitogen activated protein kinase and STAT3 signalling pathways by infliximab and etanercept in intestinal T cells from patients with Crohn's disease (multiple letter) [9]. Gut, 54(2), 314-316.

Differential modulation of p38 mitogen activated protein kinase and STAT3 signalling pathways by infliximab and etanercept in intestinal T cells from patients with Crohn's disease (multiple letter) [9]. / Rosenstiel, P.; Agnholt, J.; Kelsen, J.; Medici, V.; Waetzig, G. H.; Seegert, D.; Schreiber, S.; Di Sabatino, A.; Ciccocioppo, R.; Morera, R.; Corazza, G. R.

In: Gut, Vol. 54, No. 2, 02.2005, p. 314-316.

Research output: Contribution to journal › Article › peer-review

Rosenstiel, P, Agnholt, J, Kelsen, J, Medici, V, Waetzig, GH, Seegert, D, Schreiber, S, Di Sabatino, A, Ciccocioppo, R, Morera, R & Corazza, GR 2005, 'Differential modulation of p38 mitogen activated protein kinase and STAT3 signalling pathways by infliximab and etanercept in intestinal T cells from patients with Crohn's disease (multiple letter) [9]', Gut, vol. 54, no. 2, pp. 314-316.

Rosenstiel, P. ; Agnholt, J. ; Kelsen, J. ; Medici, V. ; Waetzig, G. H. ; Seegert, D. ; Schreiber, S. ; Di Sabatino, A. ; Ciccocioppo, R. ; Morera, R. ; Corazza, G. R. / Differential modulation of p38 mitogen activated protein kinase and STAT3 signalling pathways by infliximab and etanercept in intestinal T cells from patients with Crohn's disease (multiple letter) [9]. In: Gut. 2005 ; Vol. 54, No. 2. pp. 314-316.

@article{1797d5f7d5514103a23587b92afe59bd,

title = "Differential modulation of p38 mitogen activated protein kinase and STAT3 signalling pathways by infliximab and etanercept in intestinal T cells from patients with Crohn's disease (multiple letter) [9]",

author = "P. Rosenstiel and J. Agnholt and J. Kelsen and V. Medici and Waetzig, {G. H.} and D. Seegert and S. Schreiber and {Di Sabatino}, A. and R. Ciccocioppo and R. Morera and Corazza, {G. R.}",

year = "2005",

month = feb,

language = "English",

volume = "54",

pages = "314--316",

journal = "Gut",

issn = "0017-5749",

publisher = "BMJ Publishing Group",

number = "2",

}

TY - JOUR

T1 - Differential modulation of p38 mitogen activated protein kinase and STAT3 signalling pathways by infliximab and etanercept in intestinal T cells from patients with Crohn's disease (multiple letter) [9]

AU - Rosenstiel, P.

AU - Agnholt, J.

AU - Kelsen, J.

AU - Medici, V.

AU - Waetzig, G. H.

AU - Seegert, D.

AU - Schreiber, S.

AU - Di Sabatino, A.

AU - Ciccocioppo, R.

AU - Morera, R.

AU - Corazza, G. R.

PY - 2005/2

Y1 - 2005/2

UR - http://www.scopus.com/inward/record.url?scp=19944432266&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=19944432266&partnerID=8YFLogxK

M3 - Article

C2 - 15647208

AN - SCOPUS:19944432266

VL - 54

SP - 314

EP - 316

JO - Gut

JF - Gut

SN - 0017-5749

IS - 2

ER -

Differential modulation of p38 mitogen activated protein kinase and STAT3 signalling pathways by infliximab and etanercept in intestinal T cells from patients with Crohn's disease (multiple letter) [9]

ASJC Scopus subject areas

Other files and links

Cite this